US Stock MarketDetailed Quotes

RAPT Therapeutics (RAPT)

Watchlist
  • 57.660
  • +0.020+0.03%
Trading Jan 23 09:38 ET
1.67BMarket Cap-4.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RAPT Therapeutics (RAPT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
29.30%-12.46M
59.97%-11.27M
-93.52%-52.41M
14.17%-83.3M
62.39%-10.44M
19.48%-17.62M
2.27%-28.15M
-45.60%-27.08M
-37.13%-97.05M
-21.47%-27.75M
Net income from continuing operations
4.62%-17.58M
36.22%-17.64M
43.76%-17.17M
-11.19%-129.87M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
Operating gains losses
----
----
----
----
----
----
----
----
-204.47%-655K
--0
Depreciation and amortization
-30.98%205K
-25.25%228K
-19.75%252K
-1.07%1.2M
-11.15%287K
-8.62%297K
13.38%305K
5.02%314K
16.14%1.22M
28.17%323K
Other non cash items
-18.15%478K
0.00%584K
0.00%584K
0.04%2.34M
0.00%584K
0.17%584K
0.00%584K
0.00%584K
32.67%2.34M
22.18%584K
Change In working capital
103.55%145K
130.97%1.86M
-2,034.33%-40.04M
371.12%25.91M
3,926.46%37.88M
-170.23%-4.08M
6.84%-6.02M
-126.30%-1.88M
511.91%5.5M
65.98%-990K
-Change in prepaid assets
-57.18%438K
-267.05%-1.88M
159.73%261K
154.99%2.22M
329.60%512K
725.00%1.02M
133.96%1.12M
-189.18%-437K
161.29%871K
89.55%-223K
-Change in payables and accrued expense
107.46%328K
169.63%4.48M
-5,334.89%-39.57M
261.84%26.54M
53,747.89%38.09M
-168.89%-4.39M
-2.85%-6.43M
-110.00%-728K
97.71%7.34M
73.00%-71K
-Change in other current liabilities
12.78%-621K
-3.37%-736K
-3.38%-735K
-5.47%-2.86M
-3.45%-720K
-3.49%-712K
-3.34%-712K
-12.15%-711K
-29.09%-2.71M
-35.41%-696K
Cash from discontinued investing activities
Operating cash flow
29.30%-12.46M
59.97%-11.27M
-93.52%-52.41M
14.17%-83.3M
62.39%-10.44M
19.48%-17.62M
2.27%-28.15M
-45.60%-27.08M
-37.13%-97.05M
-21.47%-27.75M
Investing cash flow
Cash flow from continuing investing activities
-54.10%8.47M
-137.79%-7.26M
-459.19%-57.06M
-49.39%52.7M
-104.08%-843K
-28.37%18.45M
-40.77%19.21M
-37.23%15.89M
328.91%104.13M
150.01%20.64M
Net PPE purchase and sale
--0
-4,100.00%-40K
59.05%-43K
89.16%-122K
98.51%-1K
74.24%-17K
100.43%1K
86.17%-105K
-33.14%-1.13M
-36.73%-67K
Net investment purchase and sale
-54.14%8.47M
-137.59%-7.22M
-456.56%-57.02M
-49.81%52.82M
-104.07%-842K
-28.48%18.46M
-41.19%19.21M
-38.65%15.99M
335.77%105.26M
150.23%20.71M
Cash from discontinued investing activities
Investing cash flow
-54.10%8.47M
-137.79%-7.26M
-459.19%-57.06M
-49.39%52.7M
-104.08%-843K
-28.37%18.45M
-40.77%19.21M
-37.23%15.89M
328.91%104.13M
150.01%20.64M
Financing cash flow
Cash flow from continuing financing activities
36K
-77.03%161K
0
10,463.37%152.85M
31,147.82%143.12M
0
-8.60%701K
7,689.66%9.04M
-98.90%1.45M
-99.39%458K
Net common stock issuance
--0
--0
--0
--152.01M
--143.04M
--0
--0
--8.97M
--0
--0
Proceeds from stock option exercised by employees
--36K
-77.03%161K
--0
-41.60%845K
-83.19%77K
--0
-8.60%701K
-42.24%67K
3.95%1.45M
37.13%458K
Cash from discontinued financing activities
Financing cash flow
--36K
-77.03%161K
--0
10,463.37%152.85M
31,147.82%143.12M
--0
-8.60%701K
7,689.66%9.04M
-98.90%1.45M
-99.39%458K
Net cash flow
Beginning cash position
12.97%41.89M
32.97%60.26M
257.50%169.74M
21.91%47.48M
-29.99%37.9M
-26.09%37.08M
-0.99%45.32M
21.91%47.48M
62.09%38.95M
95.39%54.14M
Current changes in cash
-580.68%-3.96M
-122.95%-18.37M
-4,966.08%-109.48M
1,332.92%122.26M
2,080.40%131.84M
-79.27%823K
-287.44%-8.24M
-131.68%-2.16M
-42.81%8.53M
-159.23%-6.66M
End cash Position
0.08%37.93M
12.97%41.89M
32.97%60.26M
257.50%169.74M
257.50%169.74M
-29.99%37.9M
-26.09%37.08M
-0.99%45.32M
21.91%47.48M
21.91%47.48M
Free cash flow
29.37%-12.46M
59.82%-11.31M
-92.93%-52.46M
15.03%-83.42M
62.48%-10.44M
19.64%-17.64M
3.06%-28.15M
-40.43%-27.19M
-37.08%-98.17M
-21.50%-27.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 29.30%-12.46M59.97%-11.27M-93.52%-52.41M14.17%-83.3M62.39%-10.44M19.48%-17.62M2.27%-28.15M-45.60%-27.08M-37.13%-97.05M-21.47%-27.75M
Net income from continuing operations 4.62%-17.58M36.22%-17.64M43.76%-17.17M-11.19%-129.87M-72.46%-53.25M41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M
Operating gains losses ---------------------------------204.47%-655K--0
Depreciation and amortization -30.98%205K-25.25%228K-19.75%252K-1.07%1.2M-11.15%287K-8.62%297K13.38%305K5.02%314K16.14%1.22M28.17%323K
Other non cash items -18.15%478K0.00%584K0.00%584K0.04%2.34M0.00%584K0.17%584K0.00%584K0.00%584K32.67%2.34M22.18%584K
Change In working capital 103.55%145K130.97%1.86M-2,034.33%-40.04M371.12%25.91M3,926.46%37.88M-170.23%-4.08M6.84%-6.02M-126.30%-1.88M511.91%5.5M65.98%-990K
-Change in prepaid assets -57.18%438K-267.05%-1.88M159.73%261K154.99%2.22M329.60%512K725.00%1.02M133.96%1.12M-189.18%-437K161.29%871K89.55%-223K
-Change in payables and accrued expense 107.46%328K169.63%4.48M-5,334.89%-39.57M261.84%26.54M53,747.89%38.09M-168.89%-4.39M-2.85%-6.43M-110.00%-728K97.71%7.34M73.00%-71K
-Change in other current liabilities 12.78%-621K-3.37%-736K-3.38%-735K-5.47%-2.86M-3.45%-720K-3.49%-712K-3.34%-712K-12.15%-711K-29.09%-2.71M-35.41%-696K
Cash from discontinued investing activities
Operating cash flow 29.30%-12.46M59.97%-11.27M-93.52%-52.41M14.17%-83.3M62.39%-10.44M19.48%-17.62M2.27%-28.15M-45.60%-27.08M-37.13%-97.05M-21.47%-27.75M
Investing cash flow
Cash flow from continuing investing activities -54.10%8.47M-137.79%-7.26M-459.19%-57.06M-49.39%52.7M-104.08%-843K-28.37%18.45M-40.77%19.21M-37.23%15.89M328.91%104.13M150.01%20.64M
Net PPE purchase and sale --0-4,100.00%-40K59.05%-43K89.16%-122K98.51%-1K74.24%-17K100.43%1K86.17%-105K-33.14%-1.13M-36.73%-67K
Net investment purchase and sale -54.14%8.47M-137.59%-7.22M-456.56%-57.02M-49.81%52.82M-104.07%-842K-28.48%18.46M-41.19%19.21M-38.65%15.99M335.77%105.26M150.23%20.71M
Cash from discontinued investing activities
Investing cash flow -54.10%8.47M-137.79%-7.26M-459.19%-57.06M-49.39%52.7M-104.08%-843K-28.37%18.45M-40.77%19.21M-37.23%15.89M328.91%104.13M150.01%20.64M
Financing cash flow
Cash flow from continuing financing activities 36K-77.03%161K010,463.37%152.85M31,147.82%143.12M0-8.60%701K7,689.66%9.04M-98.90%1.45M-99.39%458K
Net common stock issuance --0--0--0--152.01M--143.04M--0--0--8.97M--0--0
Proceeds from stock option exercised by employees --36K-77.03%161K--0-41.60%845K-83.19%77K--0-8.60%701K-42.24%67K3.95%1.45M37.13%458K
Cash from discontinued financing activities
Financing cash flow --36K-77.03%161K--010,463.37%152.85M31,147.82%143.12M--0-8.60%701K7,689.66%9.04M-98.90%1.45M-99.39%458K
Net cash flow
Beginning cash position 12.97%41.89M32.97%60.26M257.50%169.74M21.91%47.48M-29.99%37.9M-26.09%37.08M-0.99%45.32M21.91%47.48M62.09%38.95M95.39%54.14M
Current changes in cash -580.68%-3.96M-122.95%-18.37M-4,966.08%-109.48M1,332.92%122.26M2,080.40%131.84M-79.27%823K-287.44%-8.24M-131.68%-2.16M-42.81%8.53M-159.23%-6.66M
End cash Position 0.08%37.93M12.97%41.89M32.97%60.26M257.50%169.74M257.50%169.74M-29.99%37.9M-26.09%37.08M-0.99%45.32M21.91%47.48M21.91%47.48M
Free cash flow 29.37%-12.46M59.82%-11.31M-92.93%-52.46M15.03%-83.42M62.48%-10.44M19.64%-17.64M3.06%-28.15M-40.43%-27.19M-37.08%-98.17M-21.50%-27.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +2.59%
Sample Name
Sample Code
 +1.74%
Sample Name
Sample Code
 +1.51%
4
Block
XYZ
+0.89%
5
Salesforce
CRM
+0.82%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.61%
Sample Name
Sample Code
 +8.39%
Sample Name
Sample Code
 +4.10%
4
H World Group
HTHT
+4.08%
5
New Oriental
EDU
+3.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -